VALUE- Vascular Access Laminate eUropean Experience. A Post Market Surveillance Study to Assess the Safety and Effectiveness of VasQ

Inclusion Criteria: 1. Patients referred for creation of a new brachiocephalic or radiocephalic fistula who consent to take part in the study. 2. Age 18-80 years 3. Male and female participants 4. Patients willing and able to attend follow up visits over a period of 12 months Exclusion Criteria: 1. Patients with the planned index procedure being a revision surgery of an existing fistula. 2. Target Brachial artery smaller than 2.5 mm or larger than 6 mm or Radial artery smaller than 2.5 mm or larger than 4 mm in outer diameter by preoperative ultrasound 3. Target vein outer diameter smaller than 2.5 mm by preoperative ultrasound 4. Significantly stenotic target vein on the side of surgery (≥50%) as diagnosed on pre-op ultrasound (scan should include the area between the planned anastomosis site and the Axillary vein) 5. Unusual anatomy or vessel dimensions (observed on pre-operative US or intraoperatively) and which preclude adequate fit of the VasQ. 6. Patients with prior central venous stenosis or obstruction on the side of surgery 7. Depth of vein greater than 8 mm (on ultrasound) on side of surgery 8. Known coagulation disorder 9. Congestive heart failure NYHA class ≥ 3 10. Prior steal on the side of surgery as evident from the patient's medical history 11. Known allergy to nitinol 12. Life expectancy less than 18 months 13. Patients expected to undergo kidney transplant within 6 months of enrollment 14. Women of child bearing potential without documented current negative pregnancy test 15. Inability to give consent and/or comply with the study follow up schedule